Answers are grounded in this paper and cite their sources.
Four different compounds belonging to the macrolide-lincosamide-streptogramin B (MLSb) class of antimicrobial agents were tested against 611 Streptococcus pneumoniae strains. The ketolide (HMR 3647, previously RU66647) and the streptogramin (quinupristin-dalfopristin) were both active against pneumococci with high-level MLSb resistance (clindamycin-resistant strains) as well as those with low-level macrolide resistance (clindamycin-susceptible strains).
No takes yet. Share an insight, caveat, or question.
Barry et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: